论文部分内容阅读
目的:探讨急性重症哮喘呼吸内科规范治疗的方法及临床疗效。方法:选取本院73例急性重症哮喘患者作为研究对象,实施常规治疗的36例为对照组,实施呼吸内科规范治疗的37例为观察组,对比分析各组临床疗效的差异。结果:观察组各项血气分析指标均显著优于对照组,观察组临床疗效总有效率显著高于对照组,均为P<0.05差异有统计学意义。结论:急性重症哮喘患者实施呼吸内科规范治疗可有效控制患者临床症状及体征,疗效确切,值得推广应用。
Objective: To investigate the method and clinical efficacy of standard medical treatment of acute respiratory syndrome in severe asthma. Methods: Seventy-three patients with acute severe asthma were selected as the research object. Thirty-six patients receiving conventional therapy were selected as the control group. Thirty-seven patients undergoing standard treatment of respiratory medicine were selected as the observation group. The differences in clinical efficacy between the two groups were analyzed. Results: The blood gas analysis indexes in the observation group were significantly better than those in the control group. The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), and the difference was statistically significant. Conclusion: The treatment of acute severe asthma patients with respiratory medicine standard treatment can effectively control the clinical symptoms and signs of patients with definite curative effect, which is worth popularizing and applying.